Is Gene Therapy for Hypertension Possible?
- 1 January 1999
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 33 (1) , 8-13
- https://doi.org/10.1161/01.hyp.33.1.8
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive RatsHuman Gene Therapy, 1998
- Cyclophosphamide Diminishes Inflammation and Prolongs Transgene Expression Following Delivery of Adenoviral Vectors to Mouse Liver and LungHuman Gene Therapy, 1996
- A Phase I Study of an Adeno-Associated Virus-CFTR Gene Vector in Adult CF Patients with Mild Lung Disease. Johns Hopkins Children's Center, Baltimore, MarylandHuman Gene Therapy, 1996
- Molecular Genetics of Human Blood Pressure VariationScience, 1996
- Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.Journal of Clinical Investigation, 1995
- Antisense inhibition of hypertension: A new strategy for renin-angiotensin candidate genesKidney International, 1994
- Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors.The Journal of Experimental Medicine, 1994
- Dual-target Inhibition of HIV-1 in Vitro by Means of an Adeno-Associated Virus Antisense VectorScience, 1992
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Recombinant Gene Expression in Vivo Within Endothelial Cells of the Arterial WallScience, 1989